Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioreactor Design and Operational System

Bioreactor Design and Operational System

Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A mechanically tunable photo-cured hydrogel system based on methacrylated collagen-keratin inter-penetrating networks for rapid and enhanced wound healing.

International journal of biological macromolecules·2026

Same author

3D-printable, heat-resistant polycaprolactone-based polymer scaffold for sustained NO release in tissue engineering applications.

Colloids and surfaces. B, Biointerfaces·2026

Same author

Harnessing Oxidized Alginate Microgels for Rapid and Self-Assembling Dental Tissue Organogenesis In Vitro and In Vivo.

Small science·2025

Same author

Sprayable, crosslinker-free, and in situ-forming Schiff-based hydrogels based on oxidized sodium alginate and carbohydrazide-modified gelatin for rapid hemostasis.

Carbohydrate polymers·2025

Same author

Biochemical and Biophysical Properties of Extracellular Matrix Nanofibers Modulate iPSC-Derived Human Hepatocyte Maturation.

Journal of biomedical materials research. Part A·2025

Same author

Effect of 2D and 3D ECM and Biomechanical Cues on Human iPSC-Derived Liver Progenitor Cell Differentiation.

Advanced healthcare materials·2025

Search research articles

Related Experiment Video

Updated: Jul 25, 2026

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

Published on: August 11, 2017

Spatial patterning strategies for liver tissue engineering: Biofabrication technologies and applications.

Haram Nah¹, Ashlin R Michell¹, Kerry M Rogy¹

¹Department of Biomedical Engineering, University of Illinois Chicago, Chicago, USA.

Advanced Drug Delivery Reviews

|November 17, 2025

Summary

Engineered liver tissues using biofabrication strategies can replicate native liver structure and function. These advanced models are crucial for drug development, disease modeling, and regenerative medicine, moving closer to clinical translation.

Keywords:

3D bioprinting Biofabrication Cell aggregates Hepatocytes Liver tissue engineering Microfluidics Spatial patterning

More Related Videos

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy

Published on: June 29, 2021

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jul 25, 2026

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

Published on: August 11, 2017

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy

Published on: June 29, 2021

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Area of Science:

Biotechnology
Regenerative Medicine
Tissue Engineering

Background:

The liver's complex cellular organization is vital for its numerous functions.
Replicating this structure is key for drug development and regenerative medicine.
Biofabrication offers methods to create engineered liver tissues.

Purpose of the Study:

To review biofabrication strategies for spatial control in engineered liver tissues.
To evaluate methods for capturing physiological features like zonation and vascular networks.
To discuss advancements in drug screening, disease modeling, and therapeutic applications.

Main Methods:

Review of self-assembled aggregates, soft lithography, electrospun scaffolds, 3D bioprinting, and microfluidics.
Evaluation of methods based on their ability to mimic native hepatic architecture.
Highlighting hybrid approaches integrating multiple biofabrication modalities.

Main Results:

Various biofabrication techniques show promise in recreating liver tissue complexity.
Engineered liver models are advancing drug metabolism and toxicity screening.
These models aid in disease modeling and exploring therapeutic applications.

Conclusions:

Engineered liver models are essential for bridging in vitro and in vivo studies.
Challenges in scalability, reproducibility, and standardization need addressing.
Future directions include volumetric bioprinting, machine learning, and regulatory qualification.